Author:
Li Yingying,Liu Hailin,Lv Qingwen,Long Jun
Abstract
Abstract
Background
Pneumocystis jirovecii pneumonia (PJP) is an interstitial pneumonia caused by pneumocystis jirovecii (PJ). The diagnosis of PJP primarily relies on the detection of the pathogen from lower respiratory tract specimens. However, it faces challenges such as difficulty in obtaining specimens and low detection rates. In the clinical diagnosis process, it is necessary to combine clinical symptoms, serological test results, chest Computed tomography (CT) images, molecular biology techniques, and metagenomics next-generation sequencing (mNGS) for comprehensive analysis.
Purpose
This study aims to overcome the limitations of traditional PJP diagnosis methods and develop a non-invasive, efficient, and accurate diagnostic approach for PJP. By using this method, patients can receive early diagnosis and treatment, effectively improving their prognosis.
Methods
We constructed an intelligent diagnostic model for PJP based on the different Convolutional Neural Networks. Firstly, we used the Convolutional Neural Network to extract CT image features from patients. Then, we fused the CT image features with clinical information features using a feature fusion function. Finally, the fused features were input into the classification network to obtain the patient's diagnosis result.
Results
In this study, for the diagnosis of PJP, the accuracy of the traditional PCR diagnostic method is 77.58%, while the mean accuracy of the optimal diagnostic model based on convolutional neural networks is 88.90%.
Conclusion
The accuracy of the diagnostic method proposed in this paper is 11.32% higher than that of the traditional PCR diagnostic method. The method proposed in this paper is an efficient, accurate, and non-invasive early diagnosis approach for PJP.
Funder
Guangzhou Science and Technology Plan Project, China.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Fannin S, Gottlieb MS, Weisman JD, et al. A cluster of Kaposi’s sarcoma and pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and range counties, California. MMWR Wkly. 1982;31(32):305–7.
2. Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010. J Infect Dis. 2016;214:862–72.
3. Avino LJ, Naylor SM, Roecker AM. Pneumocystis Jirovecii pneumonia in the non-HIV infected population. Ann Pharmacother. 2016;50(8):673–9.
4. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis Jirovecii pneumonia. Infect Dis Clin North Am. 2010;24:107e38.
5. Limper AH, Offord KP, Smith TF. Martin 2nd WJ. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989;140:1204e9.